EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI study

Florens Lohrmann, Androulla Efstratiou, Uffe B Skov Sørensen, Roberta Creti, Antoaneta Decheva, Pavla Křížová, Jana Kozáková, Javier Rodriguez-Granger, Manuel De La Rosa Fraile, Immaculada Margarit, Daniela Rinaudo, Domenico Maione und 9 weitere

Infection · 2025

DOI: 10.1007/s15010-024-02380-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Infection, 2025. Verfasst von Florens Lohrmann und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, University Medical Center, Medical Faculty, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Streptococcus agalactiae, Streptococcal Infections, Pregnancy Complications, Infectious, Carrier State. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seventh Framework Programme, GlaxoSmithKline Biologicals SA, Universitätsklinikum Freiburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Despite national guidelines and use of intrapartum antibiotic prophylaxis (IAP), Streptococcus agalactiae (group B streptococci (GBS)) is still a leading cause of morbidity and mortality in newborns in Europe and the United States. The European DEVANI (Design of a Vaccine Against Neonatal Infections) program assessed the neonatal GBS infection burden in Europe, the clinical characteristics of colonized women and microbiological data of GBS strains in colonized women and their infants with early-onset disease (EOD).

Methods

Overall, 1083 pregnant women with a GBS-positive culture result from eight European countries were included in the study. Clinical obstetrical information was collected by a standardized questionnaire. GBS strains were characterized by serological and molecular methods.

Results

Among GBS carriers included in this study after testing positive for GBS by vaginal or recto-vaginal sampling, 13.4% had at least one additional obstetrical risk factor for EOD. The five most common capsular types (i.e., Ia, Ib, II, III and V) comprised ~ 93% of GBS carried. Of the colonized women, 77.8% received any IAP, and in 49.5% the IAP was considered appropriate. In our cohort, nine neonates presented with GBS early-onset disease (EOD) with significant regional heterogeneity.

Conclusions

Screening methods and IAP rates need to be harmonized across Europe in order to reduce the rates of EOD. The epidemiological data from eight different European countries provides important information for the development of a successful GBS vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus agalactiaeStreptococcal InfectionsPregnancy Complications, InfectiousCarrier StateHumansFemaleEuropePregnancyInfant, NewbornAdultInfectious Disease Transmission, VerticalVaginaYoung AdultRisk Factors

Stichwörter der Autor:innen

Streptococcus agalactiaeEarly-onset diseaseGBS vaccineGroup B streptococcusIntrapartum prophylaxisMaternal colonizationNeonatal sepsisVertical transmission

Autor:innen und Institutionen

  • Department of Pediatrics and Adolescent Medicine, University Medical Center, Medical Faculty, University of Freiburg, Freiburg, Germany.
  • UK Health Security Agency, London, UK.
  • Department of Biomedicine, Health, Aarhus University, Aarhus, Denmark.
  • Department of Infectious Diseases, Istituto Superiore Di Sanità, Rome, Italy.
  • National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
  • National Institute of Public Health, Prague, Czech Republic.

Förderung

  • Seventh Framework Programme
  • GlaxoSmithKline Biologicals SA
  • Universitätsklinikum Freiburg

Zitieren

APA

Lohrmann, F., Efstratiou, A., Sørensen, U. B. S., Creti, R., Decheva, A., Křížová, P., Kozáková, J., Rodriguez-Granger, J., De La Rosa Fraile, M., Margarit, I., Rinaudo, D., Maione, D., Telford, J., Orefici, G., Kilian, M., Afshar, B., Melin, P., Berner, R., Hufnagel, M., …, & DEVANI Study Group (2025). Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI study. Infection. https://doi.org/10.1007/s15010-024-02380-0

Vancouver

Lohrmann F, Efstratiou A, Sørensen UBS, Creti R, Decheva A, Křížová P, et al. Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI study. Infection. 2025. doi:10.1007/s15010-024-02380-0

BibTeX
@article{Lohrmann2025,
  author = {Lohrmann, Florens and Efstratiou, Androulla and Sørensen, Uffe B Skov and Creti, Roberta and Decheva, Antoaneta and Křížová, Pavla and Kozáková, Jana and Rodriguez-Granger, Javier and De La Rosa Fraile, Manuel and Margarit, Immaculada and Rinaudo, Daniela and Maione, Domenico and Telford, John and Orefici, Graziella and Kilian, Mogens and Afshar, Baharak and Melin, Pierrette and Berner, Reinhard and Hufnagel, Markus and Kunze, Mirjam and DEVANI Study Group, DEVANI Study Group},
  title = {Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI study},
  journal = {Infection},
  year = {2025},
  doi = {10.1007/s15010-024-02380-0}
}
Kostenlos starten →